CCC
CLX icon

Crescent Capital Consulting’s Clorox CLX Stock Holding History

Crescent Capital Consulting’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$7K Hold
42
– – ﹤0.01% 416
2021
Q3 		$7K Hold
42
– – ﹤0.01% 444
2021
Q2 		$7K Buy
42
+34
+425% +$6.21K ﹤0.01% 391
2021
Q1 		$2K Hold
8
– – ﹤0.01% 447
2020
Q4 		$2K Buy
+8
New +$1.66K ﹤0.01% 405

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Crescent Capital Consulting's CLX Position: Q4 2021 in Review

Crescent Capital Consulting held its Clorox (CLX) position steady in Q4 2021 at 42 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Crescent Capital Consulting first reported a position in CLX in Q4 2020 and has held it in 5 quarters since. 1,219 funds tracked by Wall St. Rank hold CLX as of Q4 2021.

  • Crescent Capital Consulting held 42 shares of Clorox worth $7K as of Q4 2021.
  • Crescent Capital Consulting left its Clorox share count unchanged in Q4 2021.
  • Clorox made up ﹤0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #416 holding.
  • Crescent Capital Consulting first reported a position in Clorox in Q4 2020 and has held it in 5 quarters since.
  • 1,219 funds tracked by Wall St. Rank held Clorox as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.